α-ミオシン駆動免疫療法に関連するT細胞
Margaret L Axelrod1, Wouter C Meijers1,2,3, Elles M Screever1,2,3
1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Nature
|November 17, 2022
まとめ
免疫チェックポイント阻害剤 (ICI) は重度の心筋炎を引き起こす可能性があります. この研究では,CD8+ T細胞とアルファミオシンは,ICIに関連した心筋炎における重要な役割を果たし,新しい治療目標を提供している.
科学分野:
- 免疫学
- 腫瘍学
- 心臓病科
背景:
- 免疫チェックポイント阻害剤 (ICI) はがん治療に不可欠ですが,特に心筋炎などの重度の免疫関連の有害事象を引き起こす可能性があります.
- ICI関連心筋炎 (ICI-MC) の正確なメカニズムはほとんど不明であり,効果的な管理を妨げています.
研究 の 目的:
- ICI関連心筋炎の細胞および分子病原性を解明する.
- ICI-MCで標的となる特定の抗原を特定する.
主な方法:
- マウスモデルにおける心臓免疫浸透体の単細胞RNAとTCRの配列決定 (Pdcd1-/- Ctla4+/-).
- 抗CD8または抗CD4抗体を用いた in vivo 枯渇試験
- アドプティブ・トランスファー・実験
- 候補オートアンチゲンを用いたTCRクローン型分析とインビトロT細胞拡張.
主要な成果:
- クローナルエフェクタ CD8+ T細胞はICI- MCにおける支配的な免疫細胞集団として特定された.
- マウスモデルでは,CD8+ T細胞の枯渇により生存率が著しく改善されました.
- アルファミオシンは,マウスおよびICI- MC患者における特定のT細胞受容体 (TCR) の同類抗原として特定されました.
- 患者からのアルファミオシン拡張型T細胞は,病気の組織とTCRのクローンタイプを共有しました.
結論:
- 細胞毒性CD8+T細胞は,ICI-MCの病原性において重要な役割を果たします.
- アルファミオシンはICI-MCにおける重要な自己抗原であり,毒性のメカニズムに関する洞察を提供します.
- これらの発見は,ICI誘発の心臓毒性の管理のために,CD8+T細胞とアルファミオシンを標的とした新しい治療戦略を示唆する.
関連する概念動画
Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Myocarditis I: Introduction
21
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
21
Myocarditis II: Clinical Features and Diagnostic Tests
19
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Tumor Immunotherapy
631
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
631
Myocarditis IV: Nursing Management
17
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17


